How a named product from genetically modified bacteria can benefit humans?

One notable product from genetically modified bacteria is insulin, which is crucial for managing Diabetes. Bacteria, such as E. coli, can be engineered to produce human insulin by incorporating the gene responsible for insulin synthesis. This biotechnological advancement ensures a reliable and cost-effective supply of insulin, improving treatment options for millions of diabetics and significantly enhancing their quality of life. Additionally, it reduces reliance on animal sources, promoting ethical and sustainable medical practices.